“Five golden rules” for prostate cancer screening and treatment today

In a very simple and straightforward article in European Urology, Vickers et al. have clearly laid out a series of five “golden rules” that, in their opinion, all physicians should be following today when they are testing men for risk of prostate cancer through the use of the PSA test. … READ MORE …

More data that will cause controversy in the screening debate

Data from a very large, 25-year-long, randomized, controlled trial of screening for cancer has cast further doubt on the value of mass, annual, population-based screening as a way to reduce cancer deaths. … READ MORE …

UroToday interviews with D’Amico, Klotz, Mulhall

Many readers of this blog may be interested in listening to one or more of a series of recent, relatively short audio-interviews with respected opinion-leaders in the prostate cancer diagnosis and management community, conducted by the medical director of UroToday. … READ MORE …

EAU updates guidelines on screening, diagnosis, and management of localized prostate cancer

The European Association of Urology (EAU) has just updated its guideline document “EAU guidelines on prostate cancer. Part 1: Screening, diagnosis, and local treatment with curative intent”. … READ MORE …

Did unequal use of ADT in treatment affect mortality rates in the ERSPC and Göteborg trials?

A new article by Australian researchers in the Journal of the National Cancer Institute has suggested that the more widespread use of androgen deprivation therapy (ADT) among unscreened patients (controls) in the ERSPC and the Göteborg studies may have substantially affected patient mortality data in these trials. … READ MORE …

Poor guidance from the AAFP, badly interpreted by the media

According to a recent recommendation from the American Academy of Family Physicians in association with the Choosing Wisely campaign. primary care physicians are being advised as follows: … READ MORE …

Screening and its consequences: an interview with Laura Esserman

Yesterday, Medscape Oncology published a brief interview with Dr. Laura Esserman (under the title “Cancer screening: when less is more“) that will be of interest to a number of our regular readers. … READ MORE …

The PSA screening controversy: two new pro/con presentations

The “New” Prostate Cancer InfoLink finds it fascinating how, while sticking to their guns about the value of “screening” healthy men for risk of prostate cancer, the two differing groups of advocates (those “for/pro” screening and those “against/con” its) are still failing to appropriately emphasize that they are using the word “screening” with differing intent. … READ MORE …

Urologists’ and radiation oncologists’ opinions on use of PSA test to screen for prostate cancer

A new study has provided data on the opinions of a random sample of 1,366 radiation oncologists and urologists with regard to the appropriate role of the PSA test in screening for prostate cancer (since the recommendation of a D grade for this test as a screening mechanism by the U.S. Preventive Services Task Force (USPSTF). … READ MORE …

Dr. David Agus on CBS’s “Morning Rounds”

So the role of prostate cancer screening got discussed on the CBS television program “Morning Rounds” on Saturday, by Dr. David Agus (a well-known urologic oncologist) and others. The context was the recent data on the “overuse” of the PSA test in men of 75+ years of age. … READ MORE …

From Amsterdam yesterday: European perspectives on the PSA screening issue

A report on the Medscape Oncology web site, published late yesterday, discusses two presentations given yesterday at the European Cancer Conference 2013, currently being held in Amsterdam. … READ MORE …

Appropriate use of the PSA test for assessing risk of prostate cancer

The following quotation is from the abstract of a recent review of the appropriate use of the PSA test in the assessment of risk for prostate cancer: … READ MORE …

Men’s opinions on PSA testing and the USPSTF guideline: does it apply to ME?

A study just published in the American Journal of Preventive Medicine suggests that “The new USPSTF recommendation against PSA testing in all men may be met with resistance” on the part of male consumers. … READ MORE …

New “six-point” statement about prostate cancer screening (redux)

Three weeks ago we mentioned a new six-point statement about PSA screening developed at a meeting in Melbourne, Australia. We would note that an updated set of information about this statement is now available on the BJU International web site. … READ MORE …

PSA testing, life and health insurance, and full disclosure

Many readers of this blog quite certainly have strong opinions about the position of the American Cancer Society (ACS) on use of the PSA test in assessment of risk for prostate cancer. However, one does have to give credit where credit is due on a related matter. … READ MORE …

Follow

Get every new post delivered to your Inbox.

Join 1,074 other followers